B-cell receptor inhibitors in chronic lymphocytic leukemia
Flinn, I.W.
Clinical Advances in Hematology and Oncology H&o 9(8): 605-606
2011
ISSN/ISBN: 1543-0790 PMID: 22236988 Document Number: 650021
Document emailed within 1 workday
Related Documents
Rutella, S.; Rumi, C.; Puggioni, P.; Barberi, T.; Di Mario, A.; Larocca, L.M.; Leone, G. 1999: Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination Haematologica 84(5): 419-424Piro, L.D. 1993: 2-Chlorodeoxyadenosine: treatment of hairy cell leukemia, chronic lymphocytic leukemia, and lymphocytic lymphoma Seminars in Hematology 30(4 Suppl 6: 28-30
Ziegler-Heitbrock, H.W.; Munker, R.; Dörken, B.; Gaedicke, G.; Thiel, E. 1986: Induction of features characteristic of hairy cell leukemia in chronic lymphocytic leukemia and prolymphocytic leukemia cells Cancer Research 46(4 Pt 2): 2172-2178
Boddu, P.; Jain, N. 2018: Update on signal inhibitors in chronic lymphocytic leukemia Clinical Advances in Hematology and Oncology: H&o 16(4): 279-288
Rosman, I.S.; Nunley, K.S.; Lu, D. 2011: Leukemia cutis in B-cell chronic lymphocytic leukemia presenting as an episodic papulovesicular eruption Dermatology Online Journal 17(9): 7
Holbrook, N.J.; Bloomfield, C.D.; Munck, A. 1984: Stabilization of labile glucocorticoid-receptor complexes from acute nonlymphocytic leukemia cells by a factor from chronic lymphocytic leukemia cells Cancer Research 44(1): 407-414
Cacciola, E.; Calogero, D.; Marra, G.; Guglielmo, P. 1992: Serum levels of soluble interleukin-2 receptor (sIL-2R) in B-chronic lymphocytic leukemia Bollettino della Societa Italiana di Biologia Sperimentale 68(4): 259-262
Jehn, U.; Gross, H.J.; Wachholz, K.; Pauls, R. 1990: Exogenous interleukin 2 (IL 2) reconstitutes deficient in vitro T-cell growth of patients with chronic lymphocytic leukemia of B-cell lineage (B-CLL) Anticancer Research 10(4): 929-934
Porter, D.L. 2018: Advances in CAR T-cell therapy for chronic lymphocytic leukemia Clinical Advances in Hematology and Oncology: H&o 16(2): 118-120
Berrebi, A.; Shtalrid, M.; Klepfish, A.; Bassous, L.; Kushnir, M.; Shulman, L.; Vorst, E.; Hahn, T. 1994: Verapamil inhibits B-cell proliferation and tumor necrosis factor release and induces a clinical response in B-cell chronic lymphocytic leukemia Leukemia 8(12): 2214-2216
Koch, O.M.; Volkenandt, M.; Göker, E.; Buer, J.; Probst, M.; Banerjee, D.; Danenberg, P.V.; Bertino, J.R. 1994: Molecular detection and characterization of clonal cell populations in acute lymphocytic leukemia by analysis of conformational polymorphisms of cRNA molecules of rearranged T-cell-receptor-gamma and immunoglobulin heavy-chain genes Leukemia 8(6): 946-952
Potomski, J.; Harłozińska, A.; Becker, M.; Noworolska, A. 1980: Relationship between different cell surface markers in chronic lymphocytic leukemia Neoplasma 27(3): 295-300
Carlsson, M.; Tötterman, T.H.; Rosén, A.; Nilsson, K. 1989: Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells Leukemia 3(8): 593-601
Wang, M.L.; Shih, L.Y.; Dunn, P.; Kuo, M.C. 2000: Meningeal involvement in B-cell chronic lymphocytic leukemia: report of two cases Journal of the Formosan Medical Association 99(10): 775-778
Dreger, P.; Schmitz, N. 1997: The role of stem cell transplantation in the treatment of chronic lymphocytic leukemia Leukemia 11(Suppl): S42-S45
Airoldi, M.; Colombo, A.; Fantasia, R.; Colombo, G.; Gobbi, A. 1989: Chronic T-cell lymphocytic leukemia: clinical and laboratory aspects of 5 patients Recenti Progressi in Medicina 80(6): 293-296
Jablonska, E.; Kiersnowska-Rogowska, B.; Aleksandrowicz-Bukin, M.; Rogowski, F.; Sawicka-Powierza, J. 2008: TRAIL receptors in the serum of patients with B-cell chronic lymphocytic leukemia Neoplasma 55(1): 51-54
Alexander, J.L.; Kalaaji, A.N.; Shehan, J.M.; Yokel, B.K.; Pittelkow, M.R. 2006: Plasmapheresis for refractory urticarial vasculitis in a patient with B-cell chronic lymphocytic leukemia Journal of Drugs in Dermatology: Jdd 5(6): 534-537
Trbusek, M.; Mayer, J. 2004: Molecular pathogenesis of chronic lymphocytic leukemia with emphasis on cell cycle regulation and apoptosis Casopis Lekaru Ceskych 143(2): 84-89
Phyliky, R.L.; Li, C.Y.; Yam, L.T. 1983: T-cell chronic lymphocytic leukemia with morphologic and immunologic characteristics of cytotoxic/suppressor phenotype Mayo Clinic Proceedings 58(11): 709-720